The Neuromuscular Disease Network for Canada

funder-logos_nmd4c

Jodi Warman Chardon

jodi-warman

Clinician-Scientist, The Ottawa Hospital; Associate Scientist, OHRI; Scientist, CHEORI

Director, NeuroMuscular Centre, The Ottawa Hospital; Co-Director, uOBMRI Centre for Neuromuscular Disease

Email Jodi

Read more about Jodi

Biography

Dr Jodi Warman Chardon is a Clinician-Scientist in the Department of Medicine at the Ottawa Hospital, Ottawa Hospital Research Institute (OHRI) in Neurosciences and Clinical Epidemiology and Department of Genetics at the Children’s Hospital of Eastern Ontario/CHEO RI. She is a Tier 2 Clinical Research Chair in Diagnosis and Discovery Pipeline for Patients with Genetic Neuromuscular Disease and Assistant Professor of Neurology at University of Ottawa. She led the strategic development and is now Director of the Ottawa Hospital Neuromuscular Centre, a diagnostic clinical research centre for patients with NMD. She is also co-director (with Dr Robin Parks) of the uOttawa Centre for Neuromuscular Disease, which unites over 60 clinical and basic NMD researchers.

Dr Warman received her MD/Neurology residency at the University of Ottawa and MSc from Queen’s University.  She completed research and clinical fellowships in neuromuscular disorders from McGill University and neurogenetics at the University of Ottawa and is certified by the Canadian Society of Clinical Neurophysiologists (EMG).

Dr Warman’s clinical research focuses on improved genomic and imaging studies for patients with inherited myopathies and neuromuscular disorders. She represents adult NMDs as a member of the NMD4C Steering Committee and will ensure that the next generation of NMD scientists and clinicians is engaged in all activities of the work plan. She participates in genomics education for the network, leading on engaging trainees and early-career researchers.

Recent publications

Warman-Chardon, J, Diaz-Manera, J, Tasca, G, Straub, V, of the MRI workshop study group. 247th ENMC International Workshop: Muscle magnetic resonance imaging - Implementing muscle MRI as a diagnostic tool for rare genetic myopathy cohorts. Hoofddorp, The Netherlands, September 2019. Neuromuscul Disord. 2020. PMID:33004285

Hodgkinson, V, Lounsberry, J, M'Dahoma, S, Russell, A, Benstead, T, Brais, B et al.. The Canadian Neuromuscular Disease Registry 2010-2019: A Decade of Facilitating Clinical Research Through a Nationwide, Pan-Neuromuscular Disease Registry. J Neuromuscul Dis. 2020. PMID:32925088

Hodgkinson, VL, Chapman, K, Izenberg, A, Lochmüller, H, O'Connell, C, O'Ferrall, EK et al.. Response to provincial governments' decisions regarding monitoring for adults with Spinal Muscular Atrophy. Can J Neurol Sci. 2020. 1-10 PMID:32713403

Bourque, PR, Breiner, A, Warman-Chardon, J. Myofibrillar Myopathy Mimicking Polyneuropathy. Case Rep Neurol. .12 (1)97-102 PMID:32647524

Hodgkinson, VL, Oskoui, M, Lounsberry, J, M'Dahoma, S, Butler, E, Campbell, C et al.. A National Spinal Muscular Atrophy Registry for Real-World Evidence. Can J Neurol Sci. 2020. 1-6 PMID:32493524

See more on PubMed